Similar articles

• Clinicopathological Factors Associated With Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatectomy-Reply.

  Raoof M, Singh G. Raoof M, et al. JAMA Surg. 2018 Jan 1;153(1):92. doi: 10.1001/jamasurg.2017.3480. JAMA Surg. 2018. PMID: 28973297 No abstract available.
• Intrahepatic recurrence after surgery in patients with intrahepatic cholangiocarcinoma.

  Yamamoto M, Ariizumi S. Yamamoto M, et al. J Gastroenterol. 2006 Sep;41(9):925-6. doi: 10.1007/s00535-006-1901-3. J Gastroenterol. 2006. PMID: 17048061 No abstract available.
• [Current situation and evaluation of surgical treatment of hilar cholangiocarcinoma].

  Zhou NX, Chen JZ. Zhou NX, et al. Zhonghua Wai Ke Za Zhi. 2009 Aug 1;47(15):1127-9. Zhonghua Wai Ke Za Zhi. 2009. PMID: 20021899 Chinese. No abstract available.
• [Surgical treatment for intrahepatic cholangiocarcinoma].

  Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N. Nakagohri T, et al. Nihon Rinsho. 2006 Jan;64 Suppl 1:469-75. Nihon Rinsho. 2006. PMID: 16457307 Review. Japanese. No abstract available.
• Left hepatectomy or left trisectionectomy with resection of the caudate lobe and extrahepatic bile duct for hilar cholangiocarcinoma (with video).

  Uesaka K. Uesaka K. J Hepatobiliary Pancreat Sci. 2012 May;19(3):195-202. doi: 10.1007/s00534-011-0474-6. J Hepatobiliary Pancreat Sci. 2012. PMID: 22076670 Review.